The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.


Updates from The Motley Fool

Latest updates on Ariad Pharmaceuticals from Fool.com.  The Fool has written over 200 articles on Ariad Pharmaceuticals.


Stock Performance

View Interactive ARIA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Ariad Pharmaceuticals.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($0.18)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paris Panayiotopoulos, CEO

28% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Ariad Pharmaceuticals.

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers